Felbamate in Lennox-Gastaut Syndrome
Abstract
The Felbamate Study Group report results in 73 patients ages 4 to 36 years with the Lennox-Gastaut syndrome, using a double-blind, placebo- controlled, add-on trial design.
DOI: https://doi.org/10.15844/pedneurbriefs-7-1-5 | Journal eISSN: 2166-6482
Language: English
Page range: 3 - 4
Published on: Jan 1, 1993
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
© 1993 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.